Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2792891 | Cell Metabolism | 2010 | 7 Pages |
SummaryThe insulin/TOR signaling pathway plays a crucial role in animal homeostasis, sensing nutrient status to regulate organismal growth and metabolism. We identify here the Drosophila B′ regulatory subunit of PP2A (PP2A-B′) as a novel, conserved component of the insulin pathway that specifically targets the PP2A holoenzyme to dephosphorylate S6K. PP2A-B′ knockout flies have elevated S6K phosphorylation and exhibit phenotypes typical of elevated insulin signaling such as reduced total body triglycerides and reduced longevity. We show that PP2A-B′ interacts with S6K both physically and genetically. The human homolog of PP2A-B′, PPP2R5C, also counteracts S6K1 phosphorylation, indicating a conserved mechanism in mammals. Since S6K affects development of cancer and metabolic disease, our data identify PPP2R5C as a novel factor of potential medical relevance.
Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (297 K)Download as PowerPoint slideHighlights► The B′ subunit of protein phosphatase 2A (PP2A-B′) targets the holoenzyme to S6K ► PP2A-B′ knockout flies have elevated S6K phosphorylation ► PP2A-B′ mutants are lean and short-lived phenotypes of elevated S6K activity ► PP2A-B′ function is conserved in human cells